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Methicillin-resistant S. aureus (MRSA) infections are now the 
most common cause of skin abscesses. Community-associated MRSA has 
also been found to cause severe infections including necrotizing 
pneumonia, necrotizing fasciitis, purpura fulminans, and severe sepsis in 
nonimmunocompromised hosts[1]. (MRSA) strains have acquired a gene 
that makes them resistant to all beta-lactam antibiotics. Hospital-
associated strains of this organism are serious nosocomial pathogens 
that have become resistant to most common antibiotics, and treatment 
can be challenging. Community-associated MRSA strains occur in people 
who have not been hospitalized or recently had invasive procedures. 
They first appeared in high risk populations (e.g., intravenous drug users, 
people with chronic illnesses), but are now found even in healthy 
children. Until recently, community-associated strains were susceptible 
to many antibiotics other than beta-lactams; however, resistance seems 
to be increasing, and multiple antibiotic resistant strains have started to 
emerge. Human-adapted MRSA can be transmitted to animals in close 
contact, which can sometimes act as carriers and re-infect people[2]. 
MRSA strains have acquired the mecA gene, which is carried on a large 
mobile genetic element called the staphylococcal chromosomal cassette 
mec (SCCmec). This gene codes for a penicillin binding protein, PBP2a, 
which interferes with the effects of beta lactam antibiotics (e.g. penicillins 
and cephalosporins) on cell walls. It confers virtually complete resistance 
to all beta-lactam antibiotics including the semi-synthetic penicillins[3]. 
Acquisition of mecA seems to have occurred independently in a number 
of S.aureus strains. Some clonal lineages of S.aureus have a tendency to 
colonize specific species, and may be adapted to either humans or 
animals. Other lineages (“extended host spectrum genotypes”) are less 
host-specific, and can infect a wide variety of species. Some MRSA strains, 
called epidemic strains, are more prevalent and tend to spread within or 
between hospitals and countries. Other “sporadic” strains are isolated 
less frequently and do not usually spread widely[4]. Hospital-associated 
MRSA is one of the most prevalent nosocomial pathogens worldwide. 
Most infections occur in high risk patients, including the elderly and 
people with open wounds. Infections caused by community-acquired 
MRSA are also becoming more common. As with many bacterial 
infections, the case fatality rate differs with the syndrome. Mortality also 
depends on success in finding an effective antibiotic for the strain[5].  
 
2. Materials and methods  
2.1 Bacterial isolates:  
             Sixty Methicillin-resistant S. aureus (MRSA) isolates were 
obtained from clinical samples in children in Al-Hilla/Iraq during the 
period from April 2014 to June 2014. Clinical samples were collected 
from children in Al-Hilla and Babylon teaching hospital in Al-Hilla city, in 
addition to some private clinic. Clinical isolates were as follows: cellulitis, 
abscess, and wound samples. These bacterial isolates were identified as 
S.aureus based on their morphology, Gram-staining. Vitek 2 system was 
performed to identify species level and antibiotic susceptibility testing of 
S.aureus isolates.  
2.2 Antimicrobial Susceptibility Test with VITEK 2:  
            The 0.5 McFarland bacterial suspension was diluted to 1.5 × 
107 CFU/ml in 0.45% normal saline. Cards were automatically filled, 
sealed, and loaded into the VITEK 2 instrument for incubation and 
reading. The AST-GP67 card used for staphylococci contained 
benzylpenicillin, oxacillin, gentamicin, ciprofloxacin, levofloxacin, 
moxifloxacin, erythromycin, clindamycin, quinupristin/dalfopristin, 
linezolid, tetracycline, tigecycline, nitrofurantoin, rifampicin, and 
trimethoprim /sulfamethoxazole.  
 
3. Results and Discussion 
          Sixty Methicillin-resistant S. aureus (MRSA) strains clinical 
samples were collected from cellulitis, abscess, and wound samples in 
children in Al-Hilla, and Babylon teaching hospital. 24(40%) of MRSA 
isolates were community-acquired methicillin resistant Staphylococcus 
aureus (CA-MRSA), and 36(60%) were hospitalized-acquired methicillin 
resistant Staphylococcus aureus (HA-MRSA). Community associated 
MRSA strains that express a toxin called PantonValentine leucocidin 
(PVL) have been linked to skin and soft tissue infections and severe 
necrotizing pneumonia. It is possible that PVL are associated with 
increased virulence in general [6]. The two toxins (ETA and ETB) act 
specifically in the zona granulosa of the epidermis, and even 
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intraperitoneal inoculation will result in exfoliation. the toxin binds to 
proteins in keratohyalin granules, and because filaggrins act as 
intracellular anchors of desmosomes, many investigators have 
speculated that epidermal splitting is a result of rupture of these 
desmosomes, probably from proteolytic activity of the toxins [7]. Iyer and 
Jones, 2003 [8] found that cutaneous abscesses were the most common 
presentation of cutaneous MRSA infection, definitive treatment consisted 
of incision and drainage in combination with antimicrobial therapy, the 
most effective antibiotics were vancomycin, 
trimethoprim/sulfamethoxazole in combination with rifampin, and 
linezolid.  
            The results showed that 35 of female, and 25 of male of MRSA 
isolates, and these isolates were taken from 7 of infants aged less than 6 
months, and 53 children aged between 6 months and 4 years of MRSA 
isolates. Staphylococcal scalded skin syndrome (SSSS) is blistering skin 
diseases induced by the exfoliative (epidermolytic) toxins (ET) of S. 
aureus. It is a disease primarily affecting infants and young children, but 
cases have been reported in adults. It seems that the location of lesions 
depends on age. In neonates, the lesions are mostly found on the 
perineum or periumbilically, or both, while the extremities are more 
commonly affected in older children. The disease begins with erythema 
and fever, followed by formation of large fluid filled bullae which quickly 
rupture on slightest pressure to leave extensive areas of denuded skin[9]. 
Kaplan et al, 2005 [10] found that 62% of children with CA-MRSA and 
53% of CA-MSSA isolates were admitted to the hospital with skin and 
soft-tissue, and invasive infections. In this study, antimicrobial 
susceptibility testing results found that with the VITEK 2 system gave 
resistant to 10 and sensitive to 6 antibiotics to all bacterial isolates, but 
only 3(5%) of bacterial isolates were resistant to teicoplanin table (1).  
 
Table (1): Show the results of minimum inhibitory concentration 
(MIC) and interpretation with the VITEK 2 system 
 
Antimicrobial  MIC interpretation 
Benzylpenicillin  >=0.5 R 
Oxacillin  >=8 R 
Gentamicin  <=0.5 S 
Ciprofloxacin  <=0.5 S 
Levofloxacin  0.25 S 
Moxifloxacin  <=0.25 S 
Erythromycin  >=8 R 
Clindamycin  >=8 R 
Quinupristin/Dalfopristin  >=16 R 
Linezolid  >=8 R 
Teicoplannin  >=32 R 
Tetracycline  >=16 R 
Tigecycline  0.25 S 
Nitrofurantoin  256 R 
Rifampicin  >=32 R 
Trimethoprim/Sulfamethoxazole.  <=10 S 
       R: represented resistance  
       S: represented sensitive  
 
        The results showed that MRSA isolates were resistant to 
Benzylpenicillin, and oxacillin. The mechanism of resistance to β-lactam 
antibiotic is mostly due to either production of β-lactamases that 
hydrolyze β-lactam ring, or lack of penicillin receptors on cell wall and / 
or alteration in their permeability to β-lactam antibiotics preventing the 
uptaking of them [11]. Oxacillin replacs methicillin as oxacillin is stable 
under storage conditions, and methicillin actually is an excellent inducer 
of the mecA gene. Staphylococcal resistance to either oxacillin or 
methicillin occurs when the organism including an altered PBP (PBP2A) 
that is encoded by the mecA gene [12]. In the present study, the results 
found MRSA isolates were sensitive to gentamicin. The general 
mechanism of aminoglycoside resistance by Staphylococcus spp. is 
enzymatic modification, in which modifying enzymes alter various sites 
on the aminoglycosides molecules so that the ability of drug to bind the 
ribosome and halt protein synthesis will be greatly diminished or 
lost[13]. Lindqvist and his colleagues, 2009 [14] showed that 9% were 
PVL-negative erythromycin, clindamycin and tobramycin (ECT) sensitive 
MSSA.  
          MRSA isolates results showed sensitive to ciprofloxacin, 
levofloxacin, and moxifloxacin. Mitscher, 2004 [15] has stated that 
ciprofloxacin is effective against S.aureus isolates, and this type of 
antibiotic inhibits bacterial growth by effecting DNA maintenance. 
Ciprofloxacin, is bacteriocidal drug, affecting Gram positive and Gram 
negative bacteria. Generally anti Gram negative activity is more closely 
associated with DNA gyrase inhibition, whereas anti Gram positive 
activity is more closely associated with bacterial topoisomerase IV 
inhibition. DNAgyrase, and bacterial topoisomerase IV, are vital for 
dicating the proper topology of DNA which is important for protein 
biosynthesis, DNA replication and DNA repair, this interference with DNA 
transcription, replication, and repair will promote its cleavage, leading to 
rapid bacterial cell death. Also resistance to ciprofloxacin is most 
commonly associated with genetic-based alterations in the 
topoisomerases, resulting in decreased drug binding.  
            The results revealed that bacterial isolates resistant to 
erythromycin. Macrolides inhibit protein synthesis by binding to the 50S 
ribosomal subunit causing an inhibition of translocation of peptidyl-tRNA 
and the initial steps of 50S subunit assembly. The spectrum of activity of 
macrolides includes aerobic Gram positive bacteria, including 
Staphylococcus spp. [16]. MRSA isolates results showed resistant to 
clindamycin. The most common mechanism for such resistance is target 
site modification mediated by erm genes, which can be expressed either 
constitutively or inducibly [17]. Strains with inducible resistance to 
clindamycin are difficult to detect in the routine laboratory as they 
appear erythromycin-resistant and clindamycin sensitive in vitro when 
not placed adjacent to each other.  
In this study, results found that bacterial isolates resistant to 
teicoplannin. Glycopeptide antibiotics are produced by actinomycetes 
and inhibit the synthesis of bacterial cell wall by blocking peptidoglycan 
assembly. They bind to the D-alanyl-D-alanine (D-Ala-D-Ala) C terminus 
of the nascent peptidoglycan and prevent it from being utilized in the 
following cross-linking reactions catalyzed by transglycosylases and 
transpeptidases [18].  
          MRSA isolates results revealed resistant to tetracycline but 
sensitive to tigecycline. Resistance to tetracyclines occurs by three 
mechanisms (efflux, ribosomal protection, and chemical modification). 
The first two mechanisms are the most important and occur as follows: 
efflux pumps elements, located in the cytoplasmic membrane, are 
responsible for pumping the drug out of the cell. TET protein is tet 
products which responsible for protecting the ribosome, likely through 
mechanisms that induce conformational change. These conformational 
changes either prevent binding of the tetracyclines or cause their 
dissociation from the ribosome. It is often plasmid-controlled [19]. The 
bacterial isolates results found that resistant to rifampicin. Rifampin acts 
by interacting specifically with the β subunit of the bacterial RNA 
polymerase encoded by the rpoB gene. Rifampin resistance in Escherichia 
coli and S.aureus is due to alterations in the target leading to a reduced 
affinity of the enzyme for the antibiotic. Fluit and his co-workers, 2001 
[20] demonstrated that only 2% of the MSSA isolates were multidrug 
resistant (oxacillin, penicillin, gentamicin, erythromycin, clindamycin, 
ciprofloxacin, tetracycline, rifampin, and chloramphenicol), however, 
87% of the MRSA isolates were multidrug resistant and only 3% of the 
MRSA isolates were resistant to β-lactam antibiotics only.  
           The present study results showed MRSA isolates sensitive to 
trimethoprim/sulfamethoxazole. Trimethoprim is a tetrahydrofolate 
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reductase inhibitor that, when added to sulfamethoxazole, provides a 
second step block in the folate biosynthetic pathway. TMP-SMZ proved to 
be bactericidal [21]. Blocking folate metabolism at 2 sites decreased the 
emergence of resistance, nevertheless, resistance to TMP-SMZ has 
occurred because of amino acid substitutions in both enzymes, Plasmids 
(e.g., pSK41) carry the altered genes, which facilitate the spread of TMP-
SMZ resistance. Chen and his colleagues, 2006 [22] showed that 98% and 
94% of CA-MRSA were susceptible to trimethoprim/sulfamethoxazole 
and clindamycin (confirmed by D test), respectively, however, 
Randrianirina and his co-workers, 2007 [23] found that susceptibility to 
TMP-SMZ were 91%.  
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